FIELD: medicine; pharmaceutics.
SUBSTANCE: group of inventions relates to the field of medicine and pharmaceutics, namely to an antitumor agent and bromodomain inhibitor including a compound represented by the formula 1 (substituents are defined in the invention claim):
[Formula 1]
,
which has high inhibitory activity relatively to bromodomain, and which can be used as drugs during the prevention and/or therapy of a tumor related to bromodomain or another similar tumor.
EFFECT: group of inventions provides for the creation of the antitumor agent, which can be used as a drug for bromodomain-related diseases or conditions.
10 cl, 5 dwg, 36 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | 2016 |
|
RU2720205C2 |
| MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTERS | 2005 |
|
RU2528046C2 |
| MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2005 |
|
RU2556984C2 |
| METHOD OF MODULATING TRANSPORTERS OF ATP-BINDING CASSETTE | 2005 |
|
RU2525115C2 |
| ATP-BINDING CASETTE TRANSPORTER MODULATORS | 2005 |
|
RU2382779C2 |
| MODULATORS OF ATP-BINDING TRANSPORTERS | 2010 |
|
RU2552353C2 |
| QUINOLINIL-CONTAINING COMPOUND, ITS PHARMACEUTICAL COMPOSITION AND USE | 2020 |
|
RU2803116C2 |
| THIENO[2,3-c]QUINOLIN-4-ONE DERIVATIVES, USEFUL IN TREATMENT OF ERK-DEPENDENT DISEASE | 2011 |
|
RU2574398C2 |
| NOVEL AMINE DERIVATIVE OR SALT THEREOF | 2013 |
|
RU2668550C2 |
| PYRAZOLQUINOLINES WITH IMMUNOMODULATING ACTIVITY | 2003 |
|
RU2328496C2 |
